Loading interface...

Roliten OD 2 Capsule

Manufactured bySUN PHARMA LABORATORIES LTD
ContainsTolterodine
Description

Roliten OD 2 Capsule is used for the treatment of an overactive bladder, a condition characterized by symptoms such as a frequent feeling of a need to urinate, sudden urge to urinate, inability to control urination, leaking of urine, etc. This medicine is not recommended for use in patients less than 18 years of age.

Side effects

Major & minor side effects for Roliten OD 2 Capsule

  • Dry skin
  • Dry mouth
  • Abdominal pain
  • Constipation
  • Headache
  • Dizziness
  • Blurred vision
  • Dry eyes
  • Chest pain
  • Indigestion

Uses of Roliten OD 2 Capsule

What is it prescribed for?

  • Overactive Bladder
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness and drowsiness. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If this medicine is used, close monitoring of the infant for any undesired side effects is recommended.

Allergy

This medicine is not recommended for use in patients with a known allergy to tolterodine, fesoterodine, or any other inactive ingredients present along with the formulation.

Urinary retention

This medicine is not recommended for use in patients suffering from urinary retention, a condition where the patient is unable to empty the bladder, due to the increased risk of worsening of the patient's condition.

Narrow angle glaucoma

This medicine is not recommended for use in patients suffering from uncontrolled narrow-angle glaucoma due to the increased risk of worsening of the patient's condition.

Gastric retention

This medicine is not recommended for use in patients suffering from gastric retention due to the increased risk of worsening of the patient's condition.

Severe liver impairment

This medicine is not recommended for use in patients suffering from severe liver function impairment due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If this medicine is used, close monitoring of the infant for any undesired side effects is recommended.
General warnings

Use in children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Angioedema and anaphylactic reactions

This medicine may cause angioedema (swelling) of the face, lips, tongue, etc. as well as severe allergic reactions in some patients. Seek immediate medical intervention if any such reactions develop. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Central nervous system side effects

This medicine may cause central nervous system side effects such as a headache, confusion, hallucinations, sleepiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any such symptoms during treatment with this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Driving or operating machinery

The use of this medicine may cause symptoms such as dizziness, drowsiness, blurred vision, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness and drowsiness. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Ciprofloxacin

Atenolol

Topiramate

Itraconazole

Chlorpheniramine

Zonisamide

Disease interactions

Central nervous system disorders

This medicine should be used with caution in patients suffering from central nervous system disorders such as Parkinson's disease, preexisting dementia, etc. due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Myasthenia Gravis

This medicine should be used with extreme caution in patients suffering from myasthenia gravis due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

QT Prolongation

This medicine should be used with caution in patients with a known history of QT prolongation or patients receiving medications known to prolong QT interval due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine before completion of the course/without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine relaxes the urinary bladder muscles; this helps the bladder to retain a larger amount of urine and prevents the symptoms of an overactive bladder.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Urinary antispasmodics

Schedule

Schedule H

DailyMed - Tolterodine Tartrate - tolterodine capsule, extended release [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 20 June 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db6e0b6d-0ce5-41d7-881f-881c11f530a4

Tolterodine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 26 July 2018]. Available from:

https://www.drugbank.ca/drugs/DB01036

Tolterodine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 26 July 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a699026.html

Inconex XL 4 mg Prolonged-release Capsules, Hard - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2020 [cited 20 June 2020]. Available from:

https://www.medicines.org.uk/emc/product/5131/smpc
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 1 Jul 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.